Targeting HIF-2 as therapy for advanced cancers

Murugesan, T; Rajajeyabalachandran, G; Kumar, S; Nagaraju, S; Jegatheesan, SK

Murugesan, T (reprint author), Jubilant Biosys Ltd, 96 Ind Suburb 2nd Stage, Bengaluru 560022, Karnataka, India.

DRUG DISCOVERY TODAY, 2018; 23 (7): 1444

Abstract

Hypoxia-inducible factors (HIF-1 alpha, -2 alpha -3 alpha, and -beta) To are key factors that control hypoxia-induced carcinogenic pathways. HIF-1 alp......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索